Oncternal Therapeutics, Inc.

CIK 1260990 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Oncternal Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 31, 2025EFFECT9999999995-25-000849
Mar 31, 2025EFFECT9999999995-25-000850
Mar 31, 2025EFFECT9999999995-25-000851
Mar 31, 2025EFFECT9999999995-25-000854
Mar 31, 2025EFFECT9999999995-25-000848
Mar 31, 2025EFFECT9999999995-25-000867
Mar 27, 2025S-8 POS0001193125-25-064606
Mar 27, 2025S-8 POS0001193125-25-064609
Mar 27, 2025S-8 POS0001193125-25-064615
Mar 27, 2025S-8 POS0001193125-25-064612
Mar 27, 2025S-8 POS0001193125-25-064617
Mar 27, 202515-12G0001193125-25-064626
Mar 27, 2025S-8 POS0001193125-25-064620
Mar 27, 2025POS AM0001193125-25-064590
Mar 27, 2025S-8 POS0001193125-25-064608
Mar 27, 2025POS AM0001193125-25-064597
Mar 27, 2025POS AM0001193125-25-064601
Mar 27, 2025POS AM0001193125-25-064583
Mar 27, 2025S-8 POS0001193125-25-064614
Mar 27, 2025POS AM0001193125-25-064599
Mar 27, 2025POS AM0001193125-25-064605
Mar 27, 2025S-8 POS0001193125-25-064613
Mar 27, 2025S-8 POS0001193125-25-064623
Mar 27, 2025S-8 POS0001193125-25-064618
Mar 27, 2025S-8 POS0001193125-25-064611